CLINICAL_TRIALS
withdrawal
· 2018-05-07
Clinical Trial Update: Lovaza Therapy of Peripheral Arterial Disease [NA]
Summary
A clinical trial evaluating Lovaza (omega-3-acid ethyl esters) for peripheral artery disease has been withdrawn from the study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Virginia | Conditions: Peripheral Artery Disease | NA | Status: WITHDRAWN